Infection Control market By Product Type (Sterilization Equipment {Low-Temperature Equipment, Heat Sterilization Equipment, Radiation Sterilization Equipment, Liquid Sterilization Equipment}, Disinfectors {Washer Disinfectors, Endoscope Repressors, Flusher Disinfectors, Surface Disinfectants, Hand Sanitizers}, Consumables {Sterilization Supplies, Protective Apparel & Textiles, Infectious Waste Disposal}), By Infection Type (Healthcare-Associated Infections (HAIs), Community-Associated Infections, Surgical Site Infections, Urinary Tract Infections, Bloodstream Infections, Others) By Technology (Automated Sterilization Systems, Ultraviolet (UV) Disinfection, Antimicrobial Coatings, Nanotechnology-based Solutions), By Route of Administration (Oral, Injectable, Topical, Others), and By End-user (Hospitals & Clinics, Long-Term Care Facilities, Pharmaceutical & Biotechnology Companies, Research Laboratories, Ambulatory Surgical Centers, Home Healthcare), Global Market Size, Segmental analysis, Regional Overview, Company shares analysis, Leading Company Profiles And Market Forecast, 2025 – 2035
Published Date: Oct 2024 | Report ID: MI1122 | 230 Pages
Table of Contents
1. Methodology & Report Coverage
1.1. Definition & Objective
1.2. Market Evaluation & forecast parameter
1.3. Research Methodology
1.4. Data Validation Sources
1.4.1. Secondary Research
1.4.2. Primary Research
2. Market Overview
3. Infection Control Market: Market Dynamics
3.1. Executive Summary
3.2. Market Driving Factors
3.2.1. Increasing Demand for Infection Control Measures Due to Rising Healthcare-Associated Infections (HAIs)
3.2.2. Enhanced Application of E-Beam Sterilization.
3.2.3. Rising Prevalence of Infectious Diseases Driving Demand for Infection Control Measures
3.3. Key industry pitfalls & challenges
3.3.1. Challenges of High Endoscopy Reprocessing Costs and Limited Reimbursements in Developing Nations.
3.3.2. Inadequate Reimbursement Deterring Investment in Infection Control Solutions
3.3.3. Resistance to Change in Adopting New Infection Control Technologies
3.4. Market Opportunities
3.4.1. Development of Innovative Antimicrobial Materials and Coatings
3.4.2. Leveraging the Increase in Surgical Procedures to Enhance Infection Control Solutions.
3.4.3. Capitalizing on the Opportunity in Wearable Infection Monitoring Devices.
3.5. Porter’s Five Forces Analysis
3.6. PESTLE Analysis
3.7. Regulatory landscape
3.8. Investment Landscape
3.9. ESG Scenario
3.10. Competitive landscape
3.10.1. Company Market Share
3.10.2. Market Positioning
3.10.3. Strategy framework
3.10.4. Recent Acquisitions & Mergers
4. Infection Control Market, Product Type Segment Analysis
4.1. Overview Dynamics
4.1.1. Market Revenue Share, By Product Type, 2025 & 2035
4.1.2. Key Market Trends, Growth Factors, & Opportunities
4.2. Sterilization Equipment
4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)
4.2.2. Low-Temperature Equipment
4.2.2.1. Market Size and Forecast, 2025-2035 (USD Billion)
4.2.3. Heat Sterilization Equipment
4.2.3.1. Market Size and Forecast, 2025-2035 (USD Billion)
4.2.4. Radiation Sterilization Equipment
4.2.4.1. Market Size and Forecast, 2025-2035 (USD Billion)
4.2.5. Liquid Sterilization Equipment
4.2.5.1. Market Size and Forecast, 2025-2035 (USD Billion)
4.3. Disinfectors
4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)
4.3.2. Washer Disinfectors
4.3.2.1. Market Size and Forecast, 2025-2035 (USD Billion)
4.3.3. Endoscope Repressors
4.3.3.1. Market Size and Forecast, 2025-2035 (USD Billion)
4.3.4. Flusher Disinfectors
4.3.4.1. Market Size and Forecast, 2025-2035 (USD Billion)
4.3.5. Surface Disinfectants
4.3.5.1. Market Size and Forecast, 2025-2035 (USD Billion)
4.3.6. Hand Sanitizers
4.3.6.1. Market Size and Forecast, 2025-2035 (USD Billion)
4.4. Consumables
4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)
4.4.2. Sterilization Supplies
4.4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)
4.4.3. Protective Apparel & Textiles
4.4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)
4.4.4. Infectious Waste Disposal
4.4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)
5. Infection Control Market, Infection Type Analysis
5.1. Overview
5.1.1. Market Revenue Share, By Infection, 2025 & 2035
5.1.2. Key Market Trends, Growth Factors, & Opportunities
5.2. Healthcare-Associated Infections (HAIs)
5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)
5.3. Community-Associated Infections
5.3.1. Market Size and Forecast, By 2025-2035(USD Billion)
5.4. Surgical Site Infections
5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)
5.5. Urinary Tract Infections
5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)
5.6. Bloodstream Infections
5.6.1. Market Size and Forecast, 2025-2035 (USD Billion)
5.7. Others
5.7.1. Market Size and Forecast, 2025-2035 (USD Billion)
6. Infection Control Market, Technology Segment Analysis
6.1. Overview
6.1.1. Market Revenue Share, By Technology, 2025 & 2035
6.1.2. Key Market Trends, Growth Factors, & Opportunities
6.2. Automated Sterilization Systems
6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)
6.3. Ultraviolet (UV) Disinfection
6.3.1. Market Size and Forecast, By 2025-2035(USD Billion)
6.4. Antimicrobial Coatings
6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)
6.5. Nanotechnology-based Solutions
6.5.1. Market Size and Forecast, 2025-2035 (USD Billion)
7. Infection Control Market, Route of Administration Segment Analysis
7.1. Overview
7.1.1. Market Revenue Share, By Route of Administration, 2025 & 2035
7.1.2. Key Market Trends, Growth Factors, & Opportunities
7.2. Oral
7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)
7.3. Injectable
7.3.1. Market Size and Forecast, By 2025-2035(USD Billion)
7.4. Topical
7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)
7.5. Others
7.5.1. Market Size and Forecast, 2025-2035 (USD Billion)
8. Infection Control Market, End-user Segment Analysis
8.1. Overview
8.1.1. Market Revenue Share, By End-user, 2025 & 2035
8.1.2. Key Market Trends, Growth Factors, & Opportunities
8.2. Hospitals & Clinics
8.2.1. Market Size and Forecast, 2025-2035 (USD Billion)
8.3. Long-Term Care Facilities
8.3.1. Market Size and Forecast, By 2025-2035(USD Billion)
8.4. Pharmaceutical & Biotechnology Companies
8.4.1. Market Size and Forecast, 2025-2035 (USD Billion)
8.5. Research Laboratories
8.5.1. Market Size and Forecast, 2025-2035 (USD Billion)
8.6. Ambulatory Surgical Centers
8.6.1. Market Size and Forecast, 2025-2035 (USD Billion)
8.7. Home Healthcare
8.7.1. Market Size and Forecast, 2025-2035 (USD Billion)
9. Infection Control Market, Region Segment Analysis
9.1. Overview
9.1.1. Global Market Revenue Share, By Region, 2025 & 2035
9.1.2. Global Market Revenue, By Region, 2025-2035 (USD Billion)
9.2. North America
9.2.1. North America Market Revenue, By Country, 2025-2035 (USD Billion)
9.2.2. North America Market Revenue, By Product Type, 2025-2035
9.2.3. North America Market Revenue, By Infection, 2025-2035
9.2.4. North America Market Revenue, By Technology, 2025-2035
9.2.5. North America Market Revenue, By Route of Administration, 2025-2035
9.2.6. North America Market Revenue, By End-user, 2025-2035
9.2.7. The U.S.
9.2.7.1. U.S. Market Revenue, By Product Type, 2025-2035
9.2.7.2. U.S. Market Revenue, By Infection, 2025-2035
9.2.7.3. U.S. Market Revenue, By Technology, 2025-2035
9.2.7.4. U.S. Market Revenue, By Route of Administration, 2025-2035
9.2.7.5. U.S. Market Revenue, By End-user, 2025-2035
9.2.8. Canada
9.2.8.1. Canada Market Revenue, By Product Type, 2025-2035
9.2.8.2. Canada Market Revenue, By Infection, 2025-2035
9.2.8.3. Canada Market Revenue, By Technology, 2025-2035
9.2.8.4. Canada Market Revenue, By Route of Administration, 2025-2035
9.2.8.5. Canada Market Revenue, By End-user, 2025-2035
9.3. Europe
9.3.1. Europe Market Revenue, By Country, 2025-2035 (USD Billion)
9.3.2. Europe Market Revenue, By Product Type, 2025-2035
9.3.3. Europe Market Revenue, By Infection, 2025-2035
9.3.4. Europe Market Revenue, By Technology, 2025-2035
9.3.5. Europe Market Revenue, By Route of Administration, 2025-2035
9.3.6. Europe Market Revenue, By End-user, 2025-2035
9.3.7. Germany
9.3.7.1. Germany Market Revenue, By Product Type, 2025-2035
9.3.7.2. Germany Market Revenue, By Infection, 2025-2035
9.3.7.3. Germany Market Revenue, By Technology, 2025-2035
9.3.7.4. Germany Market Revenue, By Route of Administration, 2025-2035
9.3.7.5. Germany Market Revenue, By End-user, 2025-2035
9.3.8. France
9.3.8.1. France Market Revenue, By Product Type, 2025-2035
9.3.8.2. France Market Revenue, By Infection, 2025-2035
9.3.8.3. France Market Revenue, By Technology, 2025-2035
9.3.8.4. France Market Revenue, By Route of Administration, 2025-2035
9.3.8.5. France Market Revenue, By End-user, 2025-2035
9.3.9. U.K.
9.3.9.1. U.K. Market Revenue, By Product Type, 2025-2035
9.3.9.2. U.K. Market Revenue, By Infection, 2025-2035
9.3.9.3. U.K. Market Revenue, By Technology, 2025-2035
9.3.9.4. U.K. Market Revenue, By Route of Administration, 2025-2035
9.3.9.5. U.K. Market Revenue, By End-user, 2025-2035
9.3.10. Italy
9.3.10.1. Italy Market Revenue, By Product Type, 2025-2035
9.3.10.2. Italy Market Revenue, By Infection, 2025-2035
9.3.10.3. Italy Market Revenue, By Technology, 2025-2035
9.3.10.4. Italy Market Revenue, By Route of Administration, 2025-2035
9.3.10.5. Italy Market Revenue, By End-user, 2025-2035
9.3.11. Spain
9.3.11.1. Spain Market Revenue, By Product Type, 2025-2035
9.3.11.2. Spain Market Revenue, By Infection, 2025-2035
9.3.11.3. Spain Market Revenue, By Technology, 2025-2035
9.3.11.4. Spain Market Revenue, By Route of Administration, 2025-2035
9.3.11.5. Spain Market Revenue, By End-user, 2025-2035
9.3.12. Rest of Europe
9.3.12.1. Rest of Europe Market Revenue, By Product Type, 2025-2035
9.3.12.2. Rest of Europe Market Revenue, By Infection, 2025-2035
9.3.12.3. Rest of Europe Market Revenue, By Technology, 2025-2035
9.3.12.4. Rest of Europe Market Revenue, By Route of Administration, 2025-2035
9.3.12.5. Rest of Europe Market Revenue, By End-user, 2025-2035
9.4. Asia Pacific
9.4.1. Asia Pacific Market Revenue, By Country, 2025-2035 (USD Billion)
9.4.2. Asia Pacific Market Revenue, By Product Type, 2025-2035
9.4.3. Asia Pacific Market Revenue, By Infection, 2025-2035
9.4.4. Asia Pacific Market Revenue, By Technology, 2025-2035
9.4.5. Asia Pacific Market Revenue, By Route of Administration, 2025-2035
9.4.6. Asia Pacific Market Revenue, By End-user, 2025-2035
9.4.7. China
9.4.7.1. China Market Revenue, By Product Type, 2025-2035
9.4.7.2. China Market Revenue, By Infection, 2025-2035
9.4.7.3. China Market Revenue, By Technology, 2025-2035
9.4.7.4. China Market Revenue, By Route of Administration, 2025-2035
9.4.7.5. China Market Revenue, By End-user, 2025-2035
9.4.8. Japan
9.4.8.1. Japan Market Revenue, By Product Type, 2025-2035
9.4.8.2. Japan Market Revenue, By Infection, 2025-2035
9.4.8.3. Japan Market Revenue, By Technology, 2025-2035
9.4.8.4. Japan Market Revenue, By Route of Administration, 2025-2035
9.4.8.5. Japan Market Revenue, By End-user, 2025-2035
9.4.9. India
9.4.9.1. India Market Revenue, By Product Type, 2025-2035
9.4.9.2. India Market Revenue, By Infection, 2025-2035
9.4.9.3. India Market Revenue, By Technology, 2025-2035
9.4.9.4. India Market Revenue, By Route of Administration, 2025-2035
9.4.9.5. India Market Revenue, By End-user, 2025-2035
9.4.10. Australia
9.4.10.1. Australia Market Revenue, By Product Type, 2025-2035
9.4.10.2. Australia Market Revenue, By Infection, 2025-2035
9.4.10.3. Australia Market Revenue, By Technology, 2025-2035
9.4.10.4. Australia Market Revenue, By Route of Administration, 2025-2035
9.4.10.5. Australia Market Revenue, By End-user, 2025-2035
9.4.11. South Korea
9.4.11.1. South Korea Market Revenue, By Product Type, 2025-2035
9.4.11.2. South Korea Market Revenue, By Infection, 2025-2035
9.4.11.3. South Korea Market Revenue, By Technology, 2025-2035
9.4.11.4. South Korea Market Revenue, By Route of Administration, 2025-2035
9.4.11.5. South Korea Market Revenue, By End-user, 2025-2035
9.4.12. Singapore
9.4.12.1. Singapore Market Revenue, By Product Type, 2025-2035
9.4.12.2. Singapore Market Revenue, By Infection, 2025-2035
9.4.12.3. Singapore Market Revenue, By Technology, 2025-2035
9.4.12.4. Singapore Market Revenue, By Route of Administration, 2025-2035
9.4.12.5. Singapore Market Revenue, By End-user, 2025-2035
9.4.13. Rest of Asia Pacific
9.4.13.1. Rest of Asia Pacific Market Revenue, By Product Type, 2025-2035
9.4.13.2. Rest of Asia Pacific Market Revenue, By Infection, 2025-2035
9.4.13.3. Rest of Asia Pacific Market Revenue, By Technology, 2025-2035
9.4.13.4. Rest of Asia Pacific Market Revenue, By Route of Administration, 2025-2035
9.4.13.5. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035
9.5. Latin America
9.5.1. Latin America Market Revenue, By Country, 2025-2035 (USD Billion)
9.5.2. Latin America Market Revenue, By Product Type, 2025-2035
9.5.3. Latin America Market Revenue, By Infection, 2025-2035
9.5.4. Latin America Market Revenue, By Technology, 2025-2035
9.5.5. Latin America Market Revenue, By Route of Administration, 2025-2035
9.5.6. Latin America Market Revenue, By End-user, 2025-2035
9.5.7. Brazil
9.5.7.1. Brazil Market Revenue, By Product Type, 2025-2035
9.5.7.2. Brazil Market Revenue, By Infection, 2025-2035
9.5.7.3. Brazil Market Revenue, By Technology, 2025-2035
9.5.7.4. Brazil Market Revenue, By Route of Administration, 2025-2035
9.5.7.5. Brazil Market Revenue, By End-user, 2025-2035
9.5.8. Argentina
9.5.8.1. Argentina Market Revenue, By Product Type, 2025-2035
9.5.8.2. Argentina Market Revenue, By Infection, 2025-2035
9.5.8.3. Argentina Market Revenue, By Technology, 2025-2035
9.5.8.4. Argentina Market Revenue, By Route of Administration, 2025-2035
9.5.8.5. Argentina Market Revenue, By End-user, 2025-2035
9.5.9. Mexico
9.5.9.1. Mexico Market Revenue, By Product Type, 2025-2035
9.5.9.2. Mexico Market Revenue, By Infection, 2025-2035
9.5.9.3. Mexico Market Revenue, By Technology, 2025-2035
9.5.9.4. Mexico Market Revenue, By Route of Administration, 2025-2035
9.5.9.5. Mexico Market Revenue, By End-user, 2025-2035
9.5.10. Rest of Latin America
9.5.10.1. Rest of Latin America Market Revenue, By Product Type, 2025-2035
9.5.10.2. Rest of Latin America Revenue, By Infection, 2025-2035
9.5.10.3. Rest of Latin America Market Revenue, By Technology, 2025-2035
9.5.10.4. Rest of Latin America Market Revenue, By Route of Administration, 2025-2035
9.5.10.5. Rest of Latin America Market Revenue, By End-user, 2025-2035
9.6. MEA
9.6.1. MEA Market Revenue, By Country, 2025-2035 (USD Billion)
9.6.2. MEA Market Revenue, By Product Type, 2025-2035
9.6.3. MEA Market Revenue, By Infection, 2025-2035
9.6.4. MEA Market Revenue, By Technology, 2025-2035
9.6.5. MEA Market Revenue, By Route of Administration, 2025-2035
9.6.6. MEA Market Revenue, By End-user, 2025-2035
9.6.7. GCC Countries
9.6.7.1. GCC Countries Market Revenue, By Product Type, 2025-2035
9.6.7.2. GCC Countries Market Revenue, By Infection, 2025-2035
9.6.7.3. GCC Countries Market Revenue, By Technology, 2025-2035
9.6.7.4. GCC Countries Market Revenue, By Route of Administration, 2025-2035
9.6.7.5. GCC Countries Market Revenue, By End-user, 2025-2035
9.6.8. South Africa
9.6.8.1. South Africa Market Revenue, By Product Type, 2025-2035
9.6.8.2. South Africa Market Revenue, By Infection, 2025-2035
9.6.8.3. South Africa Market Revenue, By Technology, 2025-2035
9.6.8.4. South Africa Market Revenue, By Route of Administration, 2025-2035
9.6.8.5. South Africa Market Revenue, By End-user, 2025-2035
9.6.9. Rest of Middle East & Africa
9.6.9.1. Rest of Middle-East & Africa Market Revenue, By Product Type, 2025-2035
9.6.9.2. Rest of Middle East & Africa Market Revenue, By Infection, 2025-2035
9.6.9.3. Rest of Middle East & Africa Market Revenue, By Technology, 2025-2035
9.6.9.4. Rest of Middle East & Africa Market Revenue, By Route of Administration, 2025-2035
9.6.9.5. Rest of Middle East & Africa Market Revenue, By End-user, 2025-2035
10. Company Profile
10.1. STERIS PLC (Cantel Medical Corporation)
10.1.1. Business Overview
10.1.2. Financial Performance
10.1.3. Product/Service Offerings
10.1.4. Strategies & recent developments
10.1.5. SWOT Analysis
10.2. Belimed AG
10.2.1. Business Overview
10.2.2. Financial Performance
10.2.3. Product/Service Offerings
10.2.4. Strategies & recent developments
10.2.5. SWOT Analysis
10.3. Sterigenics International Inc.
10.3.1. Business Overview
10.3.2. Financial Performance
10.3.3. Product/Service Offerings
10.3.4. Strategies & recent developments
10.3.5. SWOT Analysis
10.4. Halyard Health Inc.
10.4.1. Business Overview
10.4.2. Financial Performance
10.4.3. Product/Service Offerings
10.4.4. Strategies & recent developments
10.4.5. SWOT Analysis
10.5. Ecolab Inc.
10.5.1. Business Overview
10.5.2. Financial Performance
10.5.3. Product/Service Offerings
10.5.4. Strategies & recent developments
10.5.5. SWOT Analysis
10.6. Miele Group. (Steelco)
10.6.1. Business Overview
10.6.2. Financial Performance
10.6.3. Product/Service Offerings
10.6.4. Strategies & recent developments
10.6.5. SWOT Analysis
10.7. MMM Group
10.7.1. Business Overview
10.7.2. Financial Performance
10.7.3. Product/Service Offerings
10.7.4. Strategies & recent developments
10.7.5. SWOT Analysis
10.8. Pal Internation
10.8.1. Business Overview
10.8.2. Financial Performance
10.8.3. Product/Service Offerings
10.8.4. Strategies & recent developments
10.8.5. SWOT Analysis
10.9. Metrex Research
10.9.1. Business Overview
10.9.2. Financial Performance
10.9.3. Product/Service Offerings
10.9.4. Strategies & recent developments
10.9.5. SWOT Analysis
10.10. Sotera Health Inc.
10.10.1. Business Overview
10.10.2. Financial Performance
10.10.3. Product/Service Offerings
10.10.4. Strategies & recent developments
10.10.5. SWOT Analysis
10.11. 3M Company
10.11.1. Business Overview
10.11.2. Financial Performance
10.11.3. Product/Service Offerings
10.11.4. Strategies & recent developments
10.11.5. SWOT Analysis
10.12. Matachana Group
10.12.1. Business Overview
10.12.2. Financial Performance
10.12.3. Product/Service Offerings
10.12.4. Strategies & recent developments
10.12.5. SWOT Analysis
10.13. Steris Corporation
10.13.1. Business Overview
10.13.2. Financial Performance
10.13.3. Product/Service Offerings
10.13.4. Strategies & recent developments
10.13.5. SWOT Analysis
10.14. Reckitt Benckiser
10.14.1. Business Overview
10.14.2. Financial Performance
10.14.3. Product/Service Offerings
10.14.4. Strategies & recent developments
10.14.5. SWOT Analysis
10.15. Getinge Group
10.15.1. Business Overview
10.15.2. Financial Performance
10.15.3. Product/Service Offerings
10.15.4. Strategies & recent developments
10.15.5. SWOT Analysis
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.